Price $197.77 |
Market Cap
14.9B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
25.1
|
P/B
7.9
|
P/S
6.2
|
Dividend %
-
|
|
P/CF
183.0
|
P/FCF
29.3
|
Op. Cash Flow
615.1K
|
FCF
6.6
|
|
Op. Margin
30.30%
|
Net Margin
2.30%
|
ROE
2.70%
|
ROI
14.00%
|
|
ROA
1.20%
|
EPS Growth
-88.10%
|
Current Ratio
7.0
|
Debt/Equity
84.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Wound Management Technologies (WNDM) | $0.04 | - | - | 11.1M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.49 | - | - | 61.1M | Strong Buy |
| Mentor Capital Inc (MNTR) | $0.63 | - | - | 15.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $7.55 | - | - | 41.2M | Strong Buy |
| Hologic, Inc. (HOLX) | $41.57 | - | - | 10.91B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
